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Introduction
Magnesium is an N-methyl-D-aspartate receptor blocker
and it’s known to have analgesic effect [1,2]. Hypomagne-
saemia is often seen in major surgery and it is associated
with higher morbidity, mortality, organ dysfunction, sys-
temic inflammatory response syndrome and pulmonary
hypertension [2,4]. It’s shown that intra-operative use of
magnesium sulfate reduced per-operative analgesic
requirement [5].
Objectives
The purpose of the present study is to investigate the
effects of intraoperative magnesium sulfate administra-
tion on postoperative tramadol requirement in liver
transplant patients.
Methods
Upon the approval of local ethical committee, liver
transplant patients >18 years were screened prospec-
tively between October 2014 and April 2015. All
patients were received standart anesthesia induction
(1,5 mcg/kg fentanyl, 2 mgr/kg propofol and 0,6 mg/kg
esmeron) and maintenance (MAC>0.7 sevorane, 0,05-
0,25 mcg/kg/min remifentanil and 0,15 mg/kg esmeron
per hour). Of the screened ones; 35 randomly selected
patients with normal blood magnesium level (1.8-3.6
mg/dL) were included to control group and another
35 randomly selected patients with low blood magne-
sium level
(< 1.8 mg/dL) were included to magnesium group and
given 50 mg/kg intravenous magnesium sulfate replace-
ment by the anaesthetist team. Intravenous tramadol
(0,15 mgr/kg/h infusion and 0,2 mg/kg bolus if visuel
pain scores >5) was used for postoperative analgesia for
all patients. Patient’s demographic datas, model for end-
stage liver disease (MELD) scores, lenght of time for
surgery, intra-operative magnesiun levels, APACHE II
and SOFA Scores, 24-hours tramadol requirement, time
of the first additional tramadol administration, mechani-
cal ventilation (MV) duration, length of ICU and hospi-
tal stay were recorded by the intensivists.
Results
Magnesium and control groups were similar in terms of
demographics, MELD score, length of time for surgery,
APACHE II score and length of ICU stay (p>0.05 for
each). Median intraoperative magnesium level (1.7 mg/dL
vs. 2.2 mg/dL), 24-hours tramadol requirement (3.73 mg/
kg/day vs. 4.13 mg/kg/day) and MV duration (6.0 hours
vs. 8.0 hours) of magnesium group were significantly
lower than control group whereas median time of the first
additional tramadol use (18.0 hours vs. 5.0 hours) was sig-
nificantly higher (p < 0.001 for all).
Conclusions
Intraoperative use of magnesium sulfate in the liver
transplanlation patients reduces postoperative tramadol
requirement and thus it is a candidate to be adjuvant
agent with its advantages. Besides, it may reduce MV
duration by contributing to effective analgesia without
causing respiratory depression.
Authors’ details
1Acibadem International Hospital, Intensive Care Unit, Istanbul, Turkey.
2Atasehir Memorial Hospital, Intensive Care Unit, Istanbul, Turkey. 3Atasehir
Memorial Hospital, Department of Transplantation, Istanbul, Turkey.
4Yeditepe University, PEPIRC, Istanbul, Turkey.1Acibadem International Hospital, Intensive Care Unit, Istanbul, Turkey
Full list of author information is available at the end of the article
Gucyetmez et al. Intensive Care Medicine Experimental 2015, 3(Suppl 1):A694
http://www.icm-experimental.com/content/3/S1/A694
© 2015 Gucyetmez et al.; This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided
the original work is properly cited.
Published: 1 October 2015
References
1. Chin C: Artif Organs 2013, 1:100-2.
2. James MF, et al: Br J Anaesth 2009, 103:465-7.
3. Soliman HM, et al: Crit Care Med 2003, 4:1082-7.
4. Chaunais MC, et al: Magnes Res 2012, 1:21-7.
5. Herbert K, et al: Anesth Analg 1998, 87:206-10.
doi:10.1186/2197-425X-3-S1-A694
Cite this article as: Gucyetmez et al.: Effects of intraoperative
magnesium sulfate administration on postoperative tramadol
requirement in liver transplant patients. Intensive Care Medicine
Experimental 2015 3(Suppl 1):A694.
Submit your manuscript to a 
journal and benefi t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the fi eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
Gucyetmez et al. Intensive Care Medicine Experimental 2015, 3(Suppl 1):A694
http://www.icm-experimental.com/content/3/S1/A694
Page 2 of 2
